This gradient suggests that NSE levels may correlate with the extent of neuronal involvement in diabetic neuropathy, supporting its potential role as a biomarker in characterising the condition along a severity spectrum rather than as a simple binary diagnosis [5,18]. This evidence concerns the gene ENO2 and diabetic neuropathy.